U.S. pharmacy groups applaud journalists’ deep dive into the practices of pharmacy benefits managers that increase drug costs, reduce pharmacy sustainability.
In its appeal, the AQPP denounces an ‘opaque ecosystem for the distribution of specialty drugs’ which would harm the financial health of community pharmacies and patient safety.
